State Board of Administration of Florida Retirement System’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-96,125
| Closed | -$3.87M | – | 2140 |
|
|
2026
Q1 | $3.87M | Hold |
96,125
| – | – | 0.01% | 847 |
|
|
2025
Q4 | $2.41M | Buy |
96,125
+530
| +0.6% | +$12.4K | ﹤0.01% | 987 |
|
|
2025
Q3 | $2.16M | Buy |
95,595
+4,187
| +5% | +$97.7K | ﹤0.01% | 1014 |
|
|
2025
Q2 | $1.58M | Sell |
91,408
-410
| -0.4% | -$7.59K | ﹤0.01% | 1073 |
|
|
2025
Q1 | $2.01M | Hold |
91,818
| – | – | ﹤0.01% | 993 |
|
|
2024
Q4 | $2.93M | Hold |
91,818
| – | – | 0.01% | 915 |
|
|
2024
Q3 | $2.65M | Hold |
91,818
| – | – | 0.01% | 954 |
|
|
2024
Q2 | $3.52M | Buy |
91,818
+63,702
| +227% | +$2.88M | 0.01% | 868 |
|
|
2024
Q1 | $1.85M | Sell |
28,116
-56,062
| -67% | -$3.57M | ﹤0.01% | 969 |
|
|
2023
Q4 | $5.04M | Buy |
84,178
+21,542
| +34% | +$1.09M | 0.01% | 798 |
|
|
2023
Q3 | $2.38M | Buy |
62,636
+150
| +0.2% | +$6.59K | 0.01% | 942 |
|
|
2023
Q2 | $5.69M | Buy |
62,486
+34,370
| +122% | +$2.97M | 0.01% | 749 |
|
|
2023
Q1 | $1.85M | Hold |
28,116
| – | – | ﹤0.01% | 999 |
|
|
2022
Q4 | $1.45M | Buy |
28,116
+150
| +0.5% | +$7.96K | ﹤0.01% | 1067 |
|
|
2022
Q3 | $1.91M | Hold |
27,966
| – | – | ﹤0.01% | 1002 |
|
|
2022
Q2 | $1.26M | Buy |
27,966
+1,170
| +4% | +$53.3K | ﹤0.01% | 1149 |
|
|
2022
Q1 | $1.36M | Hold |
26,796
| – | – | ﹤0.01% | 1207 |
|
|
2021
Q4 | $1.27M | Hold |
26,796
| – | – | ﹤0.01% | 1303 |
|
|
2021
Q3 | $883K | Hold |
26,796
| – | – | ﹤0.01% | 1515 |
|
|
2021
Q2 | $1.69M | Buy |
26,796
+2,901
| +12% | +$150K | ﹤0.01% | 1156 |
|
|
2021
Q1 | $1.02M | Sell |
23,895
-320
| -1% | -$15.1K | ﹤0.01% | 1399 |
|
|
2020
Q4 | $1.39M | Sell |
24,215
-700
| -3% | -$29.6K | ﹤0.01% | 1226 |
|
|
2020
Q3 | $752K | Buy |
24,915
+2,220
| +10% | +$66.3K | ﹤0.01% | 1450 |
|
|
2020
Q2 | $741K | Buy |
22,695
+2,248
| +11% | +$72.2K | ﹤0.01% | 1423 |
|
|
2020
Q1 | $548K | Buy |
20,447
+3,100
| +18% | +$110K | ﹤0.01% | 1463 |
|
|
2019
Q4 | $531K | Buy |
17,347
+160
| +0.9% | +$4.43K | ﹤0.01% | 1683 |
|
|
2019
Q3 | $414K | Hold |
17,187
| – | – | ﹤0.01% | 1779 |
|
|
2019
Q2 | $436K | Buy |
17,187
+4,720
| +38% | +$96K | ﹤0.01% | 1789 |
|
|
2019
Q1 | $243K | Hold |
12,467
| – | – | ﹤0.01% | 2064 |
|
|
2018
Q4 | $164K | Buy |
12,467
+1,659
| +15% | +$25.5K | ﹤0.01% | 2170 |
|
|
2018
Q3 | $192K | Buy |
+10,808
| New | +$200K | ﹤0.01% | 2262 |
|
Other funds holding APLS
State Board of Administration of Florida Retirement System's APLS Position: Q2 2026 in Review
State Board of Administration of Florida Retirement System sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 96,125 shares — an estimated $3.87M sold.
State Board of Administration of Florida Retirement System first reported a position in APLS in Q3 2018 and held it in 31 quarters. The position peaked at $5.69M in Q2 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- State Board of Administration of Florida Retirement System reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- State Board of Administration of Florida Retirement System sold 96,125 Apellis Pharmaceuticals shares in Q2 2026, an estimated $3.87M.
- State Board of Administration of Florida Retirement System first reported a position in Apellis Pharmaceuticals in Q3 2018 and held it in 31 quarters.
- State Board of Administration of Florida Retirement System's Apellis Pharmaceuticals position peaked at $5.69M in Q2 2023.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2026, filed 10 Aug 2026.